SEC Form 4 · accession 0001193125-26-355764
ALX ONCOLOGY HOLDINGS INC · ALXO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Lettmann
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 5:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001810182
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 17, 2026 | S | 2,230 | $1.93 | D | 294,379 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
- F2Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.